To report the authors' 7-year experience with the internal thoracic artery/radial artery (ITA/RA) T graft as the only conduits for myocardial revascularization in two-and three-vessel disease.
Summary Background Data
One and two arterial conduits provide increasing survival benefit for coronary grafting and reduce the need for reintervention. Exclusive use of arterial conduits may provide further benefit.
Methods
From October 1993 to November 2000, 1,020 patients underwent complete arterial revascularization with the ITA/RA T graft. The authors focus on the 909 having initial bypass, with a mean age of 60 and 20% age 70 or older. The incidence of triple-vessel disease was 73%, female gender 28%, diabetes mellitus 27%, peripheral vascular disease 11%, cerebrovas-cular disease 10%, and chronic obstructive pulmonary disease 6%; ejection fraction was less than 35% in 11%. Perioperative data were collected prospectively. Follow-up information was obtained at a mean of 35.4 months (range 1-88) and was 95% complete.
Results
There were seven (0.08%) deaths within 30 days of surgery. The incidence of perioperative infarction was 3.3%, low cardiac output 2.7%, stroke 2.2%, reoperation for bleeding 3.8%, and deep sternal infection 0.8%. The actuarial survival rate was 90% at 5 years, freedom from infarction was 94%, freedom from catheterization was 83%, and freedom from reintervention (angioplasty or reoperation) was 93%.
Conclusion
The ITA/RA T graft for complete arterial revascularization is associated with a low rate of perioperative death and complications and 5-year survival and freedom from reintervention values consistent with other revascularization strategies.
The radial artery (RA) was briefly used as a coronary bypass conduit in the early 1970s and was reintroduced by the same group in the early 1990s after several of the early grafts were found to be patent. 1 Anastomosis of the RA to an in situ arterial conduit 2 avoids the 15% loss of patency associated with aortic anastomosis of the right internal thoracic artery (ITA) 3 and probably all arterial conduits.
The T-graft principle allows complete arterial revascularization of the heart with both internal thoracic arteries in most patients. 4 Despite initial concerns about the technical complexity and flow capacity of this configuration, 5 we proceeded to use the radial artery in this way. 6, 7 We herein report our midterm experience with the ITA/RA T graft.
METHODS
From October 1993 to November 2000, 1,022 patients underwent anastomosis of one RA to the in situ left ITA or occasionally to the in situ or free right ITA in instances of reoperation or injury to the left ITA. In most instances complete revascularization was achieved with these conduits; 10 patients had use of the gastroepiploic artery as well. No vein grafts were used.
Demographics, surgical data, and 30-day postoperative outcomes were collected prospectively in all patients, including those from the learning curve of both surgeons. Late survival, return of angina or myocardial infarction as reported by the patient, and the occurrence of coronary angiography, coronary angioplasty, or reoperation were determined by postal questionnaire and telephone interview or from the Social Security Death Index from October 1999 to March 2001. Follow-up was 95% complete.
Patient Selection
Initially, patients were selected on the basis of younger age and low risk for adverse perioperative events, but over time selectivity decreased and this has become our preferred grafting strategy for patients younger than age 75 years. We have also included an arbitrary estimated longevity of 8 years during which survival advantage might be realized from arterial conduits. However, the occurrence of diabetes, peripheral vascular disease, and conduit availability resulted in abrogating these guidelines in some patients. Patients requiring emergency surgery and valve procedures were excluded. As noted in Table 1 , the mean age remained lower than in other contemporary series, but the prevalence of many risk factors, including female gender, diabetes melli-tus, hypertension, cigarette use, cerebral and peripheral vascular disease, and an ejection fraction of less than 35%, are comparable.
RA Harvest
After a negative (capillary reflow into the entire palm and all digits by 10 seconds) modified Allen test, the radial artery was preferentially harvested from the nondominant arm but from the dominant arm in 10%. The incision extends the length of the RA to the wrist crease to give a 20to 24-cm conduit in men, 2 cm less in women. The RA is harvested with its accompanying veins and associated areolar tissue. Initially branches were divided between small clips, but the ultrasonic scalpel is now routinely used for dissection and branch division and results in less RA spasm. 8 Topical papaverine (6 mg/mL in lactated Ringer solution) is sprayed on the RA when spasm occurs during harvesting and occasionally after anastomosis. The RA is placed in room-temperature heparinized blood with papaverine 2 mg/mL until used.
Surgical Technique
In 1995 we shifted from hypothermic bypass with cold blood cardioplegia to tepid (33-34°C) for both with the usual antegrade cardioplegia delivery and occasional retrograde delivery, except for routine use in reoperative coronary grafting.
The opened pericardium is incised across the pulmonic valve into the fat-free "bare area" of the pericardium to the phrenic nerve. Systemic heparin (300 units/kg) is given and the RA is anastomosed to the pleural aspect of the left ITA at the level of entry into the pericardial space adjacent or just anterior to the left atrial appendage. After anastomosis both conduits are filled with heparinized blood and papaverine (2 mg/mL) and allowed to dilate under arterial pressure while cannulation is performed.
Usually the left ITA is directed to the left anterior descending system and the radial artery to the circumflex system and the right coronary branches. Occasionally the left ITA is targeted on a circumflex branch and the radial artery goes to the anterior coronary and over the acute margin of the heart to the posterior descending artery. Radial artery anastomoses are completed first beginning proximally. Initially all side-to-side anastomoses were parallel, but if more than two anastomoses are placed with the RA, there may not be adequate length. For this reason we have shifted to crossing (diamond) anastomoses for the RA when length is a concern.
Intravenous nicardipine, nitroglycerin, or both are frequently infused during surgery and for as long as 12 to 24 hours after surgery without the use of oral agents, except early in our experience. 9 Vitamin C (200 mg/hour) is given intravenously to all patients with diabetes until they can take 500 mg by mouth four times daily, which continues for at least 1 month. 10
Statistical Analysis
All continuous data were expressed as mean Ϯ standard deviation or as percentages, as indicated. Actuarial survival and freedom from cardiac events were determined using the Kaplan-Meier method. Univariate analysis of risk factors for early and late events was performed, and factors found to trend toward significance (P Ͻ .15) were entered into multivariate analysis. A stepwise multivariate Cox regression model was then constructed using these factors to determine independent predictors of late events (P Ͻ .05). The Friedman nonparametric t test was used to compare the preoperative and postoperative angina class (Canadian Cardiovascular Society [CCS]). P Ͻ .05 was considered significant for all statistical calculations. SYSTAT system for statistics was used for all data analysis (version 6.0 for Windows; SPSS, Chicago, IL). Table 1 presents data for all 1,020 patients and those (n ϭ 909) undergoing first-time coronary bypass; the latter group forms the basis of this report. Preoperative variables were not different in the two groups. The mean age was 60 (20% were 70 or older) and 28% were female. Diabetes was present in 27%, 11% had an ejection fraction of less than 35%, and 72% had triple-vessel disease (the remainder had two-vessel disease). The CCS angina class was 3 or 4 in 77%.
RESULTS

Patient Characteristics
Surgical Characteristics
Most patients (91%) had elective operations. There were 3.53 distal anastomoses per patient, of which 2.18 were with the RA and 1.35 with the ITA. Pump time was 119 minutes (range 53-267) and cross-clamp time was 98 minutes (range 0 -204), with two operations performed off-pump.
Death and Complications at 30 Days
There were seven (0.9%) deaths ( Table 2) . Perioperative infarction (new Q wave) occurred in 35 patients (3.3%), low cardiac output in 24 (2.7%), stroke in 20 (2.2%), dialysis in three (0.3%), ventricular arrhythmia in 18 (2.4%), and reoperation for bleeding in 35 (3.8%). Diabetes mellitus was present in two of seven (0.8%) patients with deep sternal infection. In two patients intraoperative hypoperfusion was corrected by proximal mobilization of the ITA to relieve tension on the RA. Hand ischemia did not occur and arm complications were limited to two instances of cellulitis. Trauma to the superficial radial nerve manifest by pain, paresthesias, or numbness was present in 15% of patients in this interval.
Late Follow-Up
Mean follow-up was 35.4 months (range 1-88). The mean CCS angina class improved from 2.77 to 1.88 (P Ͻ .001), and the incidence of myocardial infarction was 3.8% (n ϭ 35). These two end points were self-reported.
There were 52 (5.7%) late deaths. Cardiac catheterization was performed in 97 patients (10.6%), coronary angioplasty in 33 (3.6%), and reoperative coronary bypass in 5 (0.6%) ( Table 3) .
Cox regression analysis of preoperative and operative variables and postoperative risk factors was performed, followed by stepwise regression analysis of the risk factors found to be significant for all deaths to provide an optimal predictive model. Variables predictive of death are presented in Table 4 . Significant preoperative variables were age, renal disease, peripheral vascular disease, and chronic obstructive pulmonary disease. No surgical variables were predictive of death. Postoperative variables predictive of death were postoperative renal dialysis and ventricular tachyarrhythmia; stroke was of marginal significance (P ϭ .06). 
Radial Artery T Graft
The survival curve for 909 patients (Fig. 1) includes early deaths and reveals a 94% survival rate at 3 years and 90% at 5 years. Freedom from myocardial infarction (patientreported) was 94% at 5 years. Freedom from cardiac catheterization was 83% at 5 years. At 5 years freedom from reintervention (coronary angioplasty or reoperative coronary bypass) was 93% (Fig. 2 ).
DISCUSSION
Our results show that complete arterial revascularization with the ITA/RA T graft in selected patients can be achieved with low perioperative rates of death and complications. Rates of 5-year survival and freedom from reintervention are similar to those reported for patients undergoing the standard operation (left ITA to left anterior descending coronary and saphenous vein for other targets). 11 Our out-comes are also similar to those reported for bilateral ITA grafting 11 and for use of the radial artery with the left ITA in addition to saphenous vein grafts 12 or use of the RA with both ITAs. 13 Only longer observation, and ideally randomization, will determine whether our strategy is inferior to, comparable to, or better than these other combinations of conduits.
Comorbidities for perioperative death in the bilateral ITA series (age, female gender, and peripheral vascular disease) were more prevalent in our patients, but our patients underwent surgery in a later era. 11 The same risk factors also influenced late death in the bilateral ITA series, 11 but only age and peripheral vascular disease did so in our experience. When one radial artery, the left ITA, and saphenous vein were used, rates of complications and perioperative death were influenced by age older than 70, triple-vessel disease, and CCS angina class 4, the first two of which were more prevalent in our patients. 12 The same risk factors affected late events in addition to diabetes, which was more common in their patients than ours. 12
Complete Arterial Revascularization
Several reports have suggested that two arterial conduits (bilateral ITA) as opposed to one provide greater freedom from ischemic events without improved survival. 14 -16 Others have shown improved survival as well as a reduced need for revascularization (coronary angioplasty or reoperation). 11, 17, 18 Whether it will ever be shown that survival can be improved over that attained with two arterial conduits seems doubtful. A prospective randomized study is unlikely. The choice of grafting targets after the first two (assuming they are the best) is frequently limited by coronary size, extent of atherosclerosis, location on the heart, and the health of the myocardium. These latter issues not only limit the potential benefit of the graft but also have an impact (at least the first three) on conduit patency. Thus, although the expectation of survival benefit is unrealistic, improved conduit patency may result in fewer ischemic events and decrease the need for angiography, coronary angioplasty, and reoperation. These potential benefits justify continued efforts to expand our use of arterial conduits if there is no downside.
Radial Artery
In searching for a third arterial conduit (in addition to the ITAs), it became apparent that the inferior epigastric artery, despite excellent patency as a Y graft, 2 is limited by its length, 19 whereas the gastroepiploic artery has significant variability in its size 20 and patency comparable to saphenous vein at 10 years. 21 The RA has had a more rapid ascendency during one decade than any arterial conduit, as exemplified by reports from Buenos Aires, 13 Chieti, 2 Melbourne, 22 New York, 23 and Toronto. 12 The RA is the longest arterial conduit, less fragile and somewhat larger than the ITA, and dissection has not occurred. The thicker media of the RA is also more reactive than that of the ITA, 24 -26 so that harvest spasm is more profound. We vigorously treat harvest spasm with intraluminal and topical papaverine and have not experienced problematic hypoperfusion. Postoperative spasm with hypoperfusion and the need for reoperation with supplemental vein grafting have not occurred.
Why T Grafting?
Moving the right ITA to the aorta entails a 10% to 15% loss of patency at 10 years. 3, 27 Grafting a free arterial conduit to an in situ arterial conduit overcomes the inherent problem of attaching a small-caliber tube to a large-caliber tube with a thick wall. Because the opening in the aorta must be relatively small to accommodate the smaller conduit, healing may be associated with stenosis or occlusion. Also, the T anastomosis lengthens the free conduit by 10 cm, allowing it to reach most targets unless the heart is enlarged.
Concerns about the T graft center on technical complexity and the potential for hypoperfusion. We have not recognized failure of the T anastomosis. Some RAs have closed distally and thrombosed to the ITA, leaving the anastomosis imperceptible angiographically and without compromise of ITA flow. Side-to-side anastomosis with arterial conduit is more difficult, but 20 years of experience with the left ITA to the left anterior descending system and this report, where 35% of the ITAs were used sequentially, has not revealed a loss of patency either at the side-to-side anastomosis or distally. 27, 28 We have always preferred parallel anastomosis but have switched to diamond anastomosis when RA length is an issue (more than two anastomoses), despite a 10% loss in patency with the latter technique for the ITA. 27 Supplying the heart through a single source of inflow (the proximal ITA) is intuitively worrisome. However, the ITA is progressively larger proximally. Much of the blood flow to the heart is through the native circulation even with severe triple-vessel disease. The potential for flow through the T graft (free flow) is 2.3 times greater than the measured flow at the end of the operation. 29 Flow reserve of the T graft (constructed with right ITA or RA) was reduced at 1 week after surgery but approached expected coronary flow reserve at 6 months. 30 Conduit spasm or technical imperfection may result in hypoperfusion with any arterial conduit, but we have not recognized intrinsic inadequacy of the ITA/RA T graft as a cause.
Conduit Patency
Reported 5-year patency rates for RA grafts from the aorta were 83% 31 and 87%. 32 When the RA was based on an in situ ITA graft, patency was 94% (35 grafts) at a mean follow-up of 21 months. 2 In the above reports, angiography was performed in a prospective analysis of outcome. Angiography in 15 patients with signs or symptoms of ischemia revealed an RA patency rate of 60% at a mean of 13.5 months. 13 In 109 patients suspected of having ischemia, angiography at a mean of 28 months (range 2-72) showed an RA anastomotic patency of 70% (231 anastomoses) when used as a T graft. 28 Comparison of conduit patency to the gold standard (left ITA to left anterior descending) reveals equal patency for either conduit to the left anterior descending and lateral circumflex branches. 28, 33 RA patency is reduced if the coronary stenosis is less than 70% and when right coronary branches are grafted. 28 In the current era, the saphenous vein patency rate is 72.5% versus an ITA patency rate of 95.5% at a mean of 7.5 years. 27 Patency for the ITA is reduced when it is free, when the target is more distal, and when coronary stenosis is less than 60%. 3
Study Limitations
All patients were selected by the surgeon with the inherent bias to choose low-risk patients for this new strategy. When using a new technique it is necessary to avoid early deaths and complications, which would prejudice against the innovation before longer-term results could accrue and be assessed. Because rates of complications and deaths were acceptably low in the first half of this experience, we were comfortable in expanding the indications for this approach. Thus, this report represents only interim information when at least 10 years of observation is needed. the past 3 years, 90% of patients age 75 or younger having a first-time isolated coronary artery bypass underwent ITA/RA T grafting. Patients having ongoing ischemia as a result of acute vessel closure or shock were excluded, as were those requiring a valve operation. Exclusion for an ejection fraction of less than 35% was based on age, the potential for improvement suggested by thallium stress testing, and life expectancy (8 years). Morbid obesity, diabetes, peripheral vascular disease, and chronic obstructive pulmonary disease were not exclusions; in fact, we believe patients with these comorbidities are better served with the ITA/RA T graft. Harvest of the RA in the obese is easier than vein harvest and the incision is virtually complication-free; in those with peripheral vascular disease, the saphenous vein is preserved for peripheral vascular reconstruction; in the diabetic population, associated vasculopathy and impaired healing favor vein preservation and an arm incision.
We will continue to use the RA T graft with the same enthusiasm as we have to the time of this report, with the exception of not grafting (with the RA) vessels having less than 70% stenosis. We recognize that there may be better options for the right coronary branches, 3 but it is not clear which.
We have not abandoned the right ITA, but we believe that the RA is more suitable for the T-graft configuration because of reduced sternal complications, simultaneous harvest, greater conduit length, larger diameter, and comparable patency for coronary stenosis of more than 70%.
Discussion
DR. TIMOTHY J. GARDNER (Philadelphia, Pennsylvania): This is an excellent report. We admire Dr. Barner for his commitment and perseverance over the years to all-arterial grafting. He has been there in the lead at times when many surgeons were skeptical about the usefulness or the need for arterial grafting, and we compliment you on your persistence.
But I would ask you why, in this time, you believe that it is so important to avoid the use of saphenous vein grafts in selected situations. We still, I think, are overly impressed, perhaps, by the early data about the risk of saphenous vein graft occlusion, which was reported to be as high as 50% at ten years in data that was presented in the mid-1980s.
Since that time, we have seen many patients who have come back with patent vein grafts after 15 to 20 years. The routine use of secondary prevention techniques -in particular, aggressive lowering of LDL cholesterol, routine use of aspirin and so on -has, I think, improved the longevity prospects for saphenous veins.
In addition, I am rather surprised that you have abandoned the regular or routine use of RIMA, the right internal mammary artery, which doesn't have the susceptibility to vasospasm that the radial artery graft is known to have.
Finally, you mentioned that you have not recognized any case of hypoperfusion related to the single left mammary artery supplying the entire bypass circulation. I recently reviewed a mortality case of a patient who had a coronary artery bypass grafting times four based on a left internal mammary artery, and with two radial artery grafts taken off of the IMA. The patient had a difficult and confusing postoperative course where myocardial ischemia was not obvious. But when he died four days later and had a post-mortem exam, it was obvious that he had extensive subendocardial ischemia of the entire left ventricle which was mildly hypertrophied. I believe that without question the cause was hypoperfusion, especially in retrospect looking back at his symptoms.
Those who have measured IMA flow have frequently been concerned about the initial relatively low flow that we see in the perioperative period. So I wonder whether we really can be quite as confident about this particular configuration as you are, and whether there is really any compelling reason to do it this way rather than to use aortic anastomoses. PRESENTER DR. HENDRICK B. BARNER (St. Louis, Missouri): There is no doubt that saphenous vein patency is better today than it was and will likely continue to improve. However, some veins will continue to develop atherosclerosis which will lead to conduit failure which we have not recognized in the internal thoracic artery with 25 years of angiographic follow-up with the exception of the rare instance of ostial stenosis at the origin of the internal thoracic artery.
We initiated this experience as a natural evolution in our expanding use of arterial conduits to achieve complete arterial revascularization. We have not abandoned the right internal thoracic artery but wanted to accumulate a large experience over a short period of time with the radial artery. We were also attracted to the T-graft principle which allows complete revascularization with two conduits. When one of these is the radial artery the issue of sternal infection with bilateral internal thoracic artery harvest in the diabetic, the obese and those with chronic obstructive pulmonary disease is avoided. Additionally in those with peripheral vascular disease the vein is preserved for peripheral vascular reconstruction.
An additional benefit of radial artery harvest is that it is done while the left internal artery is mobilized. Our surgical assistants prefer to harvest the radial artery rather than vein in the obese. Healing complications in the arm are rare and patient satisfaction was an unanticipated benefit.
Hypoperfusion is a potential complication with any arterial conduit. Those with experience have learned that this occurrence decreases with experience and that it is usually related to technical or procedural errors and conduct spasm. All of these are preventable or treatable. Our incidence of hypoperfusion is less than 1% and it has invariably been recognized and corrected at the time of the original operation and without the need for return to the operating room or supplemental vein grafts. Rarely we have found that the internal thoracic artery was too small or had inadequate free flow probably due to orificial stenosis.
We recognize that the complexity of the T-graft and the single source of inflow can potentially compromises the result and that many will be uncomfortable with this configuration. We believe it has certain advantages as suggested and will continue to use it as we have with the modification of the necessity for at least 70% coronary stenosis in radial artery targets. Radial Artery T Graft
